Esin Izat

To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.

Following a new product’s first year on the market, there are four key ways companies can refine commercial strategies to maximize product sales.